Neuro-Bio Limited

BioTech/Drugs - , , UK

Neuro-Bio Limited Details

‘Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE. T14 is neurotoxic in the adult brain and published data shows it to be a potential key driver of neurodegeneration. This new distinct mechanism is being exploited by Neuro-Bio to discover first-in-class drugs to treat Alzheimer's disease and to develop a biomarker as a companion diagnostic'.

Neuro-Bio Limited logo, Neuro-Bio Limited contact details
Website: neuro-bio.com
Employees: 20 - 49
HQ: 44-1235-420085
Location: , , UK
Revenue: 2.5 - 5 Million
Neurobiology Neurodegeneration Drug discovery Biomarker development Biotechnology CNS Disorders
Neuro-Bio Limited Technologies
Email Providers

Outlook

Widgets

Google translate widget

Fonts

Google Font API

Tag Management

Google Tag Manager

Other

Mobile Friendly

View All Technologies Used At Neuro-Bio Limited

Contacting Neuro-Bio Limited: Connect with Executives and Employees

Get in Touch with Neuro-Bio Limited Executives and Employees

Connecting with Neuro-Bio Limited's Executives and Workforce

Accessing Contact Information for Neuro-Bio Limited Executives

Connecting with Neuro-Bio Limited: Reach Out to Their Team

Discover How to Contact Neuro-Bio Limited Executives and Staff

Looking to connect with Neuro-Bio Limited executives or employees?

Seeking to Get in Touch with Neuro-Bio Limited Executives or Staff?

Want to Reach Out to Neuro-Bio Limited Executives or Team Members?

In Search of Contact Details for Neuro-Bio Limited Professionals?

Connecting with Neuro-Bio Limited: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z